| Name | 2-(4-(((7-(diethylamino)-2,4-dioxo-2H-chromen-3(4H)-ylidene)methyl)amino)phenyl)-N'-1,2,3,4-tetrahydroacridin-9-ylacetohydrazide |
|---|
| Description | PE154 (Compound 13) is a potent fluorescent inhibitor of human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) (IC50s=280 pM and 16 nM, respectively)[1]. PE154 can label β-amyloid plaques in histochemical analysis[2]. |
|---|---|
| Related Catalog | |
| Target |
Butyrylcholinesterase:16 nM (IC50) Acetylcholinesterase:280 pM (IC50) |
| In Vivo | PE154 (hippocampus injection; 0.2 μg per mouse; once) can stain the histochemical of cortical βamyloid plaques[2]. Animal Model: 13–20-month-old triple-transgenic mice harbouring three mutant genes (APPswe, PS-1 and tauP301L)[2] Dosage: 0.2 μg per mouse Administration: Hippocampus injection; 0.2 μg per mouse; once Result: Showed the histochemical staining of cortical βamyloid plaques in triple-transgenic (TTG) mice. |
| References |
| Molecular Formula | C35H35N5O4 |
|---|---|
| Molecular Weight | 589.68300 |
| Exact Mass | 589.26900 |
| PSA | 112.66000 |
| LogP | 6.28020 |
| RIDADR | NONH for all modes of transport |
|---|